Ex-Date | Pay Date | Amount | Change |
---|---|---|---|
CN¥0.15 | 0% | ||
CN¥0.15 | 0% | ||
CN¥0.15 | 20% | ||
CN¥0.15 | 20% | ||
CN¥0.125 | 15.74% | ||
CN¥0.108 | 28.57% | ||
CN¥0.084 | 5% | ||
CN¥0.08 | 0% | ||
CN¥0.08 | 14.29% | ||
CN¥0.07 | 40% | ||
CN¥0.05 | 0% | ||
CN¥0.05 | 25% | ||
CN¥0.04 | 0% |
Jiangsu Lianhuan Pharmaceutical Co Ltd Class A pays a dividend yield (FWD) of 1.58%.
- ISIN
- WKN
- Symbol / Exchange
- / XSHG
- Value
- €1.22
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Within the last 12 months, Jiangsu Lianhuan Pharmaceutical Co Ltd Class A paid a dividend of CN¥0.15. For the next 12 months, Jiangsu Lianhuan Pharmaceutical Co Ltd Class A is expected to pay a dividend of CN¥0.15. This corresponds to a dividend yield of approximately 1.58%.
- The dividend yield of Jiangsu Lianhuan Pharmaceutical Co Ltd Class A is currently 1.58%.
- Jiangsu Lianhuan Pharmaceutical Co Ltd Class A pays annually dividends. Payout is in May.
- The next dividend for Jiangsu Lianhuan Pharmaceutical Co Ltd Class A is expected in May.
- Jiangsu Lianhuan Pharmaceutical Co Ltd Class A paid dividend every year within the last 10 years.
- Dividends of CN¥0.15 are expected for the next 12 months. This corresponds to a dividend yield of 1.58%.
- Jiangsu Lianhuan Pharmaceutical Co Ltd Class A is assigned to the sector "Health Care".
- The last stock split of Jiangsu Lianhuan Pharmaceutical Co Ltd Class A was on 4 June 2010 in the ratio 13:10.
- To receive the last dividend of Jiangsu Lianhuan Pharmaceutical Co Ltd Class A on 24 May 2024 in the amount of CN¥0.15 you had to have the stock in your portfolio before the ex-day on 24 May 2024.
- The last dividend was paid on 24 May 2024.
- In 2022, dividends of CN¥0.13 were paid by Jiangsu Lianhuan Pharmaceutical Co Ltd Class A.
- Dividends from Jiangsu Lianhuan Pharmaceutical Co Ltd Class A are paid in Chinese Yuan.
- The headquarters of Jiangsu Lianhuan Pharmaceutical Co Ltd Class A is located in China.